Enterprise Architecture
The Hidden Cost of Cheap AI: Why Model Tier Choice Matters

Abbas Al Masri
Founder & Chief Executive Officer, Hayya Med AI
2026-07-12 · 6 min read
The line item that says a model costs a fraction of a cent per call is not the real price. The real price shows up later, in every human hour spent catching what the cheap model got wrong.
Procurement Optimizes for the Wrong Number
When a procurement team compares AI vendors or model providers, the number they gravitate toward is cost per token or cost per call, because it is the number that is easiest to put in a spreadsheet and compare across options. It is also, for most enterprise use cases, close to the least important number in the decision. A model that is a fraction of the cost per call but wrong twice as often does not save money; it moves the cost from a line item finance can see to a line item finance never sees, buried in the hours a human spends reviewing, correcting, or simply not trusting the system's output. I have watched this exact substitution happen at companies that were genuinely proud of the per-call savings they negotiated, without ever measuring what it cost them downstream.
The downstream cost is not hypothetical and it is not small in aggregate. Every wrong output that reaches a customer, a regulator, or a clinician has to be caught by someone, and if it is not caught, it becomes a reputational or compliance incident instead of a review-queue item. Once you account for the reviewer's time, the rework, and the trust the system slowly loses from the people meant to rely on it, the cheap model is very often the more expensive choice, just with the cost moved somewhere procurement was not asked to look.
Not Every Task Deserves the Same Model
The mistake in the other direction is just as real and just as costly: running every single task through the most expensive frontier model available, on the theory that more capability is always safer. It is not. A high-volume, low-stakes task like classifying incoming support tickets by category does not need the same model as a task that drafts a clinical summary a physician will act on. Routing both through the frontier model wastes money on the easy task without buying any additional safety on the hard one, because the actual risk in that pipeline was never about raw model capability in the first place — it was about how much human oversight the high-stakes output receives before anyone acts on it.
The architecture that actually holds up under scrutiny is tiered by task, not uniform by default. Cheap, fast models handle the high-volume classification and routing work where errors are low-stakes and easily caught. Mid-tier models handle drafting and summarization where a human reviews before anything ships. The most capable, most expensive models get reserved for the genuinely hard judgment calls, where the cost of the model is trivial compared to the cost of getting the judgment wrong. Getting this tiering right requires actually mapping which decisions in a workflow are high-stakes and which are not, which is unglamorous work that most teams skip because it is easier to just pick one model and use it everywhere.
How We Tier Model Choice at Hayya Med AI
Every system we build starts with a map of the decisions inside it, ranked by what happens if the AI gets each one wrong, and the model tier assigned to each step follows from that map rather than from whichever model happens to be cheapest or newest that quarter. This means a single client deployment might run three or four different model tiers across its pipeline, which is more complex to build and maintain than picking one model and calling it done. We accept that complexity because the alternative, a single model tier applied uniformly regardless of stakes, is the pattern most likely to either overspend on trivial tasks or under-protect the tasks that actually matter, and in a regulated sector like healthcare, under-protecting the wrong step is not a cost you get to absorb quietly.

Written by Abbas Al Masri
Founder & Chief Executive Officer, Hayya Med AI
Abbas Al Masri founded Hayya Med AI to help organizations across the GCC and beyond build AI-native platforms grounded in real market, regulatory, and operational reality.
View Full Profile →More Insights
AI Strategy
How Artificial Intelligence Will Reshape Our Near Future
AI in Industry
AI Across Industries: Healthcare, Real Estate, Marketing, and Business Operations
Enterprise Architecture
Why Enterprise Software Fails Without AI-Native Architecture
AI Agents
The Real ROI of AI Agents in Business Automation
AI Governance
Why AI Governance Can't Be an Afterthought
Global Expansion
AI Adoption Playbook for GCC Family Businesses Going Global
AI Governance
Why Data Residency Rules Will Shape the Next Decade of GCC AI
AI Strategy
Building Bilingual AI: Lessons From Deploying Arabic-First Systems
AI Strategy
From Pilot to Production: Why Most Enterprise AI Projects Stall
AI in Industry
AI and National Vision 2030 Strategies: A Practical Look at Qatar
AI Strategy
What CEOs Get Wrong About Generative AI ROI
AI Governance
Why Every AI Vendor Should Show You Their Fallback Plan
Enterprise Architecture
The Real Difference Between an AI Feature and an AI Product
Enterprise Architecture
How Multi-Country SaaS Should Architect for Compliance From Day One
AI in Industry
AI in Cross-Border E-Commerce: What Actually Changes at Scale
AI Strategy
The Founder's Guide to Choosing an AI Development Partner
AI Agents
Why Voice AI Is the Most Underrated Customer Experience Investment
AI Governance
Explainability Isn't Optional: A CEO's Guide to Trustworthy AI
AI in Industry
What We Learned Building AI for Regulated Healthcare Markets
AI Agents
The Economics of AI Agents: When Automation Actually Pays for Itself
AI Strategy
Why Most 'AI Strategy' Documents Never Ship Anything
AI Governance
Data Sovereignty in the GCC: What Every Enterprise Needs to Know
Global Expansion
Scaling AI From One Market to Fifteen: What Actually Transfers
AI Strategy
The Next Five Years of Enterprise AI in the Gulf
Healthcare AI
The Physician Still Makes the Call: AI Diagnostics Over the Next Decade
Precision Medicine
Precision Medicine Was Always the Goal, AI Is What Makes It Affordable
AI in Medicine
What AI Actually Changes About Drug Discovery, and What It Doesn't
Health Systems
The Hospital of the Future Isn't Robots, It's a Scheduling System That Actually Works
Telemedicine
Telemedicine's Next Chapter Is Triage, Translation, and Trust
Healthcare AI
Can AI Actually Solve the Healthcare Workforce Shortage?
Preventive Care
AI Is Moving Healthcare's Center of Gravity From Treatment to Prevention
Mental Health
The Future of Mental Health Care Needs AI in the Right Place, Not Every Place
Healthcare Equity
AI Could Widen the Healthcare Access Gap. It Doesn't Have To.
Future of Healthcare
What Healthcare Will Actually Look Like in Ten Years
